NOK155.50
2.20% today
Oslo, Nov 26, 03:38 pm CET
ISIN
NO0010159684
Symbol
MEDI
Sector

Medistim Target price 2024 - Analyst rating & recommendation

Medistim Classifications & Recommendation:

Hold
100%

Medistim Price Target

Target Price NOK166.00
Price NOK154.50
Potential
Number of Estimates 2
2 Analysts have issued a price target Medistim 2025 . The average Medistim target price is NOK166.00. This is higher than the current stock price. The highest price target is
NOK172.00 11.33%
register free of charge
, the lowest is .
A rating was issued by 2 analysts: 0 Analysts recommend Medistim to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medistim stock has an average upside potential 2025 of . Most analysts recommend the Medistim stock at Hold.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million NOK 521.11 553.50
7.17% 6.22%
EBITDA Margin 28.76% 29.36%
8.55% 2.10%
Net Margin 19.96% 19.68%
15.20% 1.39%

2 Analysts have issued a sales forecast Medistim 2024 . The average Medistim sales estimate is

NOK554m
Unlock
. This is
1.17% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
NOK560m 2.36%
Unlock
, the lowest is
NOK547m 0.01%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 NOK521m 7.17%
2024
NOK554m 6.22%
Unlock
2025
NOK589m 6.32%
Unlock
2026
NOK584m 0.85%
Unlock

2 Analysts have issued an Medistim EBITDA forecast 2024. The average Medistim EBITDA estimate is

NOK163m
Unlock
. This is
6.56% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
NOK163m 6.89%
Unlock
, the lowest is
NOK162m 6.23%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 NOK150m 2.00%
2024
NOK163m 8.44%
Unlock
2025
NOK171m 4.92%
Unlock
2026
NOK166m 2.64%
Unlock

EBITDA Margin

2023 28.76% 8.55%
2024
29.36% 2.10%
Unlock
2025
28.97% 1.33%
Unlock
2026
28.45% 1.79%
Unlock

1 Analyst has issued a net profit forecast Medistim 2024 . The average Medistim net profit estimate is

NOK109m
Unlock
. This is
7.20% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
NOK109m 7.20%
Unlock
, the lowest is
NOK109m 7.20%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 NOK104m 9.12%
2024
NOK109m 4.75%
Unlock
2025
NOK110m 0.84%
Unlock
2026
NOK114m 4.00%
Unlock

Net Margin

2023 19.96% 15.20%
2024
19.68% 1.39%
Unlock
2025
18.67% 5.13%
Unlock
2026
19.58% 4.87%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share NOK 5.68 5.95
9.12% 4.75%
P/E 26.72
EV/Sales 5.06

1 Analysts have issued a Medistim forecast for earnings per share. The average Medistim <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

NOK5.95
Unlock
. This is
7.21% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
NOK5.95 7.21%
Unlock
, the lowest is
NOK5.95 7.21%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 NOK5.68 9.12%
2024
NOK5.95 4.75%
Unlock
2025
NOK6.00 0.84%
Unlock
2026
NOK6.24 4.00%
Unlock

P/E ratio

Current 28.64 8.09%
2024
26.72 6.70%
Unlock
2025
26.50 0.82%
Unlock
2026
25.48 3.85%
Unlock

Based on analysts' sales estimates for 2024, the Medistim stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.12 22.89%
2024
5.06 1.12%
Unlock
2025
4.76 5.95%
Unlock
2026
4.80 0.86%
Unlock

P/S ratio

Current 5.32 22.39%
2024
5.26 1.16%
Unlock
2025
4.95 5.95%
Unlock
2026
4.99 0.86%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today